A
$ Value
$0
Shares
9,999
Price
$0
Filed
Jun 13
Insider
Name
Kronenfeld Mark A.
Title
—
CIK
0001578074
Roles
Director
Transaction Details
Transaction Date
2025-06-11
Code
A
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
34,901
Footnotes
Represents restricted stock units that vest on June 11, 2026, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock. | The stock option vests and becomes exercisable on June 11, 2026, provided that the reporting person remains in continuous service with the issuer through the vesting date.
Filing Info
Kronenfeld Mark A.'s History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2025-06-11 | PCRX | A | $0 |
| 2025-06-11 | PCRX | A | $0 |
| 2025-06-11 | PCRX | A | $0 |
Other Insiders at PCRX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
WILLIAMS KRISTEN
Chief Administrative Officer
|
— | $270K | 2026-02-11 |
|
RIKER LAUREN
Senior Vice President, Finance
|
— | $83K | 2026-02-11 |
| Kronenfeld Mark A. | — | — | 2025-06-11 |
| Froimson Mark | — | $11K | 2026-03-17 |
|
Cross Shawn
Chief Financial Officer
|
— | $303K | 2026-04-22 |
| Hirawat Samit | — | — | 2026-01-27 |
|
Lee Frank D.
Chief Executive Officer
|
— | — | 2026-02-11 |
|
SLONIN JONATHAN
Chief Medical Officer
|
— | $74K | 2026-03-17 |
|
Teehan Brendan
Chief Commercial Officer
|
— | — | 2026-02-11 |